First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
COHEN, Mauricio G, PURDY, Drew A, ZELENKOFSKE, Steven, ALEXANDER, John H, HARRINGTON, Robert A, RUSCONI, Christopher P, BECKER, Richard C, ROSSI, Joseph S, GRINFELD, Liliana R, MYLES, Shelley K, ABERLE, Laura H, GREENBAUM, Adam B, FRY, Edward, CHAN, Mark Y, TONKENS, Ross M
Published in Circulation (New York, N.Y.) (10.08.2010)
Published in Circulation (New York, N.Y.) (10.08.2010)
Get full text
Journal Article
Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
CHAN, Mark Y, COHEN, Mauricio G, VORCHHEIMER, David A, CHRONOS, Nicholas, MELLONI, Chiara, ALEXANDER, John H, HARRINGTON, Robert A, TONKENS, Ross M, BECKER, Richard C, RUSCONI, Christopher P, DYKE, Christopher K, MYLES, Shelley K, ABERLE, Laura G, MIN LIN, WALDER, James, STEINHUBL, Steven R, GILCHRIST, Ian C, KLEIMAN, Neal S
Published in Circulation (New York, N.Y.) (03.06.2008)
Published in Circulation (New York, N.Y.) (03.06.2008)
Get full text
Journal Article
Abstract 2780: A First-in-Class Oligonucleotide Drug-Antidote Pair Efficiently Modulates Factor IXa Activity in Human Subjects - A Nascent Platform for Antidote-Controlled Periprocedural Anticoagulation
Chan, Mark Y, Cohen, Mauricio G, Rusconi, Christopher P, Alexander, John H, Myles, Shelley K, Aberle, Laura G, Lin, Min, Melloni, Chiara, Tonkens, Ross M, Harrington, Robert A, Becker, Richard C
Published in Circulation (New York, N.Y.) (16.10.2007)
Published in Circulation (New York, N.Y.) (16.10.2007)
Get full text
Journal Article